1 |
|
|
Conditions: |
|
Pulmonary Hypertension; Chronic Thromboembolic Pulmonary Hypertension |
Intervention: |
|
Behavioral: exercise and respiratory therapy |
|
2 |
|
|
Conditions: |
|
Pulmonary Arterial Hypertension; Pulmonary Hypertension |
Interventions: |
|
Drug: Sitaxsentan; Drug: Bosentan, Ambrisentan |
|
3 |
|
|
Conditions: |
|
Pulmonary Arterial Hypertension; Idiopathic Pulmonary Fibrosis; Interstitial Lung Disease; Pulmonary Hypertension |
Interventions: |
|
Drug: sildenafil; Drug: sildenafil |
|
4 |
|
|
Conditions: |
|
Systemic Sclerosis; Pulmonary Arterial Hypertension; Pulmonary Hypertension |
Intervention: |
|
|
|
5 |
|
|
Conditions: |
|
Secondary Pulmonary Arterial Hypertension; Sickle Cell Disease; Pulmonary Hypertension |
Intervention: |
|
|
|
6 |
|
|
Conditions: |
|
Preeclampsia; Pregnancy Induced Hypertension; Gestational Hypertension; Chronic Hypertension; Superimposed Preeclampsia |
Interventions: |
|
Drug: labetalol (seizure prevention); Drug: MgSO4 (seizure prevention) |
|
7 |
|
|
Conditions: |
|
Mild Essential Hypertension; Moderate Essential Hypertension |
Intervention: |
|
Biological: CYT006-AngQb |
|
8 |
|
|
Conditions: |
|
Pregnancy Toxemia; Hypertension; Proteinuria |
Interventions: |
|
Drug: methyldopa; Drug: labetalol; Drug: nifedipine; Drug: clonidine |
|
9 |
|
|
Conditions: |
|
Pulmonary Arterial Hypertension; Idiopathic Pulmonary Fibrosis |
Interventions: |
|
Drug: bosentan; Other: No specific intervention; Other: No specific intervention |
|
10 |
|
|
Conditions: |
|
Diabetes Mellitus; Hypertension |
Interventions: |
|
Behavioral: Diet: total fat < 5%, saturated fat < 10%, vegetables, fruit; Behavioral: Moderate exercise (30 min at least 5 times/week); Drug: enalapril tablets; Drug: losartan tablets; Drug: placebo tablets |
|
11 |
|
|
Condition: |
|
Hypertension, Pulmonary |
Intervention: |
|
Drug: simvastatin |
|
12 |
|
|
Condition: |
|
Pulmonary Hypertension |
Intervention: |
|
Drug: escitalopram |
|
13 |
|
|
Condition: |
|
Chronic Thromboembolic Pulmonary Hypertension |
Intervention: |
|
Other: Angiography and Computed Tomography |
|
14 |
|
|
Condition: |
|
Pulmonary Hypertension |
Interventions: |
|
Drug: Nitric Oxide/INP Pulse Delivery; Drug: Nitric Oxide/INO Pulse Delivery |
|
15 |
|
|
Condition: |
|
Hypertension, Pulmonary |
Interventions: |
|
Procedure: Excerise Training; Procedure: Patient Education (Placebo) |
|
16 |
|
|
Condition: |
|
Pulmonary Hypertension |
Intervention: |
|
Drug: Inhaled Iloprost |
|
17 |
|
|
Condition: |
|
Pulmonary Hypertension |
Intervention: |
|
Drug: aerosolized iloprost |
|
18 |
|
|
Conditions: |
|
Sleep Disordered Breathing; Obstructive Sleep Apnea; Gestational Hypertension; Preeclampsia |
Interventions: |
|
Device: CPAP; Device: Oral Appliance |
|
19 |
|
|
Condition: |
|
Pulmonary Hypertension |
Interventions: |
|
Drug: bosentan; Drug: placebo |
|
20 |
|
|
Condition: |
|
Pulmonary Arterial Hypertension |
Intervention: |
|
Device: ETED, CPET, RHC |
|
21 |
|
|
Condition: |
|
Hypertension |
Intervention: |
|
Drug: spironolactone |
|
22 |
|
|
Conditions: |
|
Open-Angle Glaucoma; Ocular Hypertension |
Intervention: |
|
Drug: Travoprost/Timolol |
|
23 |
|
|
Conditions: |
|
Adult Respiratory Distress Syndrome; Pulmonary Hypertension |
Interventions: |
|
Drug: PGE1; Drug: normal saline |
|
24 |
|
|
Condition: |
|
Pulmonary Hypertension |
Intervention: |
|
Procedure: for BMPR II study |
|
25 |
|
|
Condition: |
|
Pulmonary Arterial Hypertension |
Interventions: |
|
Drug: iloprost power 15 ( Ventavis(R)); Drug: placebo |
|
26 |
|
|
Conditions: |
|
COPD; Pulmonary Hypertension |
Interventions: |
|
Drug: sildenafil; Drug: placebo |
|
27 |
|
|
Conditions: |
|
Primary Myelofibrosis; Primary Pulmonary Hypertension; Secondary Myelofibrosis; Pulmonary Arterial Hypertension |
Intervention: |
|
|
|
28 |
|
|
Condition: |
|
Pulmonary Hypertension |
Intervention: |
|
Drug: sildenafil citrate |
|
29 |
|
|
Condition: |
|
Hypertension, Pulmonary |
Interventions: |
|
Drug: Simvastatin; Drug: Aspirin; Drug: Placebo |
|
30 |
|
|
Conditions: |
|
Sickle Cell Disease; Pulmonary Hypertension |
Intervention: |
|
Drug: Hydroxyurea |
|
31 |
|
|
Condition: |
|
Primary and Secondary Pulmonary Hypertension |
Intervention: |
|
Drug: type-5 phosphodiesterase Inhibitor (Sildenafil) |
|
32 |
|
|
Conditions: |
|
COPD; Pulmonary Hypertension |
Intervention: |
|
|
|
33 |
|
|
Conditions: |
|
Chuvash Polycythemia; Cerebrovascular Disease; Pulmonary Hypertension; Sickle Cell Anemia |
Intervention: |
|
|
|
34 |
|
|
Conditions: |
|
Systemic Sclerosis; Scleroderma; Pulmonary Hypertension |
Intervention: |
|
|
|
35 |
|
|
Condition: |
|
Hypertension |
Intervention: |
|
Behavioral: Endurance exercise |
|
36 |
|
|
Condition: |
|
Pulmonary Hypertension |
Interventions: |
|
Drug: Vardenafil; Drug: Placebo; Drug: Vardenafil |
|
37 |
|
|
Conditions: |
|
Pulmonary Fibrosis; Pulmonary Hypertension |
Intervention: |
|
Drug: Iloprost inhalation |
|
38 |
|
|
Conditions: |
|
Sickle Cell Disease; Pulmonary Hypertension |
Interventions: |
|
Drug: Sildenafil; Drug: Placebo |
|
39 |
|
|
Condition: |
|
Hypertension, Pulmonary |
Interventions: |
|
Procedure: Heart Catheterization; Drug: Nitric Oxide; Drug: Nitric Oxide/INO Pulse Delivery; Drug: Sodium Nitrite |
|
40 |
|
|
Condition: |
|
Hypertension |
Interventions: |
|
Drug: BQ123; Drug: Trimethaphan; Drug: Clonidine; Drug: Nitroglycerin transdermal; Drug: Dipyridamole/ Aspirin (Aggrenox); Drug: Desmopressin (DDAVP); Drug: Sildenafil; Drug: Nifedipine; Drug: Hydralazine; Drug: Hydrochlorothiazide; Drug: Placebo; Drug: Bosentan; Drug: Diltiazem; Drug: Eplerenone; Drug: guanfacine; Dietary Supplement: L-arginine |
|
41 |
|
|
Conditions: |
|
Sleep Apnea; Hypertension |
Intervention: |
|
Device: CPAP |
|
42 |
|
|
Conditions: |
|
Pulmonary Arterial Hypertension; Interstitial Lung Disease; Idiopathic Pulmonary Fibrosis |
Intervention: |
|
Drug: treprostinil |
|
43 |
|
|
Conditions: |
|
Cirrhosis; Portal Hypertension |
Intervention: |
|
Drug: carvedilol or propranolol |
|
44 |
|
|
Condition: |
|
Pulmonary Hypertension |
Intervention: |
|
Drug: Inhaled Treprostinil Sodium |
|
45 |
|
|
Conditions: |
|
Pulmonary Hypertension; Sickle Cell Anemia |
Intervention: |
|
|
|
46 |
|
|
Condition: |
|
Pulmonary Arterial Hypertension |
Intervention: |
|
Drug: sapropterin dihydrochloride |
|
47 |
|
|
Condition: |
|
Pulmonary Arterial Hypertension |
Interventions: |
|
Drug: ACT-064992; Drug: ACT-064992; Drug: Placebo |
|
48 |
|
|
Condition: |
|
Pulmonary Arterial Hypertension |
Intervention: |
|
Drug: iloprost |
|
49 |
|
|
Condition: |
|
Pulmonary Hypertension |
Intervention: |
|
Drug: Oral treprostinil (UT-15C) Sustained Release Tablets |
|
50 |
|
|
Condition: |
|
Pulmonary Arterial Hypertension |
Intervention: |
|
Drug: Sorafenib |
|